Nine out of ten people living with rare diseases across Europe have been negatively impacted by the coronavirus pandemic, including three out of ten who said that this has caused “life-threatening” disruption, according to a recent study by EURORDIS-Rare Diseases Europe.
Stakeholders across the EU are calling for action on medicine shortages, which they say pose severe threats to patient outcomes, patient safety and patient care. A new report released on Monday (27 April) hopes to help plug the gap.
The Commission will kick-off the discussion on the 'Europe's beating cancer plan' next 4 February on the occasion of the world cancer day, while the communication and action plan itself is expected towards the end of 2020, Health Commissioner Stella Ky...
Germany's regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA).
Faced with the numerous difficulties of access to medicine in Africa, African states want to organise the market to increase local production, which currently accounts for 3% of world output.
Low quality and fake medicines kill tens of thousands of people each year, most of them in developing countries. Yet data and political action to address the enormous human and economic cost is distinctly thin on the ground.